Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients

針對症狀 Chronic Lymphocytic Leukemia
臨床試驗編號 NCT00058656
臨床階段 Phase I/II
臨床試驗位址 4 Study Locations
目前研究進度 This study has been completed.
試驗開始日期 April 8, 2003
試驗開始日期 November 20, 2006
臨床目的 Patients will have immune cells collected and then expanded outside of the body. Patients will receive an infusion of a large number of expanded immune cells. There will be three dose levels studied. The goal of the study will be to determine the safety as well as potential efficacy of this treatment.